Q1 Earnings Highs And Lows: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks
1 S&P 500 Stock Worth Investigating and 2 That Underwhelm
Kidney care leader launches its next chapter of measurable impact for patients, teammates, and communities.
1 Momentum Stock to Own for Decades and 2 We Avoid
/DaVita%20Inc%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
DaVita has outpaced the broader market over the past year, with Wall Street analysts maintaining a cautiously optimistic outlook on the stock’s long-term prospects.
The 5 Most Interesting Analyst Questions From DaVita’s Q1 Earnings Call
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
June S&P 500 E-Mini futures (ESM26) are up +0.03%, and June Nasdaq 100 E-Mini futures (NQM26) are down -0.01% this morning as investors await the outcome of diplomatic efforts aimed at ending the Iran...
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +1.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.08%. June E-mini...